Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 15/20 | 0.65 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2159796 | 0.88 | FOLH1 (0.50) | FOLH1CYP1A2 | |
| SCHEMBL13753333 | 0.83 | FOLH1 (0.71) | FOLH1GRM3NAALAD2CYP1A2 | |
| SCHEMBL31198158 | 0.82 | TDP1 (0.42) | FOLH1 | |
| SCHEMBL7541278 | 0.81 | CHRM1 (0.62) | FOLH1 | |
| SCHEMBL14574037 | 0.81 | CHRM1 (0.62) | FOLH1 | |
| SCHEMBL9514344 | 0.80 | FOLH1 (0.48) | FOLH1 | |
| SCHEMBL9725558 | 0.80 | FOLH1 (0.48) | FOLH1 | |
| SCHEMBL28640 | 0.80 | FOLH1 (1.00) | FOLH1GRM3NAALAD2 | |
| SCHEMBL9188814 | 0.79 | FOLH1 (0.65) | FOLH1GRM3NAALAD2 | |
| SCHEMBL31756901 | 0.78 | CHRM1 (0.50) | FOLH1GRM3NAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1797868-A1 | Cosmetic composition comprising a (thio)urethane/(thio)urea copolymer capable of forming at least 3 hydrogen bonds, and process for cosmetic treatment | L'Oréal (FR) | 2007-06-20 | — | — | EP | claimed |
| EP-1773903-B1 | SUPRAMOLECULAR IONOMERS | SUPRAPOLIX BV (NL) | 2017-08-09 | — | — | EP | disclosed |
| US-9089500-B2 | Cosmetic treatment processes and kit | L'OREAL (FR) | 2015-07-28 | — | — | US | disclosed |
| US-20140155352-A1 | COSMETIC TREATMENT PROCESSES AND KIT | L'OREAL (FR) | 2014-06-05 | — | — | US | disclosed |
| EP-2729118-A2 | COSMETIC TREATMENT PROCESSES AND KIT | L'OREAL (FR) | 2014-05-14 | — | — | EP | disclosed |
| WO-2013004982-A2 | COSMETIC TREATMENT PROCESSES AND KIT | L'OREAL (FR) | 2013-01-10 | — | — | WO | disclosed |
| US-8268952-B2 | Supramolecular ionomers | SUPRAPOLIX B.V. (NL) | 2012-09-18 | — | — | US | disclosed |
| WO-2011083243-A1 | COSMETIC TREATMENT METHODS AND KIT | L'OREAL (FR) | 2011-07-14 | — | — | WO | disclosed |
| US-20090111930-A1 | Supramolecular Ionomers | SUPRAPOLIX B. V. | 2009-04-30 | — | — | US | disclosed |
| EP-1797868-A1 | Cosmetic composition comprising a (thio)urethane/(thio)urea copolymer capable of forming at least 3 hydrogen bonds, and process for cosmetic treatment | L'Oréal (FR) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140155352-A1 | COSMETIC TREATMENT PROCESSES AND KIT | KIT, KRT18, MKI67 | FOLH1 1115/4885GRM3 4861/4885NAALAD2 2768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.